FindTrial
Sign In

Clinical efficacy of Xiaoyu powder combined with traditional Chinese and Western medicine in the treatment of primary osteoporosis with low back pain

Clinical efficacy of Xiaoyu powder combined with traditional Chinese and Western medicine in the treatment of primary osteoporosis with low back pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003699
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

Xiaoyu powder syndrome differentiation and treatment along meridians application method combined with conventional anti osteoporosis treatment group:Treatment of Xiaoyu powder based on syndrome differ
According to the syndrome differentiation and treatment of placebo combined with routine anti osteoporosis treatment group:Application of placebo based on syndrome differentiation and treatment along

Sponsors

Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) According to the diagnostic criteria of osteoporosis in Western Medicine (brittle fracture or / and t value =1 month; (3) No anti osteoporosis treatment or drugs affecting bone mineral density (BMD) were used in the past month; (4) Volunteer to participate in clinical trials and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Secondary osteoporosis; (2) Relevant treatment has been carried out recently; (3) Allergic to related drugs; (4) Patients with severe heart disease, severe liver and kidney dysfunction, malignant hypertension, severe heart failure, severe arrhythmia, lumbar or hip implants, osteomalacia, primary hyperparathyroidism, diabetes, psychosis and other diseases affecting bone metabolism; (5) Unwilling to participate in clinical trials.

Design outcomes

Primary

MeasureTime frame
bone density;Pain VAS score;—

Secondary

MeasureTime frame
Biochemical indexes of bone metabolism;TCM symptom score;Osteoporotic cone compression fractures;Quality of life indicators;—

Countries

China

Contacts

Public ContactTeng Weiran

Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University

tengwr@hotmail.com+86 13818537040

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026